Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Microalbuminuria, Endothelial Dysfunction, Diabetic Nephropathy or Diabetic Retinopathy
and you are
over 18
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

Microalbuminuria (MA) is an independent cardiovascular risk factor in diabetic and non-diabetic subjects. However, in the setting of type 2 diabetes, microalbuminuria could be a marker of either early diabetic nephropathy or diffuse endothelial dysfunction. At present, there are no biomarkers that permit us to discriminate between these two conditions.

Provided treatments

  • Other: non intervention
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02409511. The sponsor of the trial is Hospital Universitari Vall d'Hebron Research Institute and it is looking for 75 volunteers for the current phase.
Official trial title:
Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)